Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Parenthetical)

v2.4.0.8
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Parenthetical) (Research and Development Expense [Member], USD $)
In Thousands, unless otherwise specified
3 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Research and Development Expense [Member]
   
Operating expenses, related party $ 222 $ 153